Elevance Health (ELV) Q4 CY2024 Highlights: Revenue: $45.44 billion vs analyst estimates of $45.34 billion (6.6% year-on-year growth, in line) Adjusted EPS: $3.84 vs analyst expectations of $3.85 ...

Health insurance provider Elevance Health (NYSE:EVH) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 6.6% year on year to $45.44 billion. Its non-GAAP profit of $3.84 per share was ...

Analysts' ratings for Elevance Health (NYSE:ELV) over the last quarter vary from bullish to bearish, as provided by 6 analysts. Summarizing their recent assessments, the table below illustrates ...

Gwyneth Paltrow recently sold her 8,000-square-foot mansion in Brentwood’s Mandeville Canyon for $22 million, though this price fell short of her initial asking price. According to the Wall ...

Gail Boudreaux; President, Chief Executive Officer, Director; Elevance Health Inc Mark Kaye; Chief Financial Officer, Executive Vice President; Elevance Health Inc Felicia Norwood; Executive Vice ...

In this article, we are going to take a look at where Elevance Health, Inc. (NYSE:ELV) stands against the other large-cap value stocks. The market outlook is as uncertain as it gets. On January 18 ...

Elevance Health (ELV – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Scott Fidel from Stephens downgraded the rating on the stock to a ...

But rules insurers such as Blue Cross Blue Shield of Michigan, UnitedHealthcare and Elevance Health have recently announced may be a new battleground in the age-old fight between the two camps.

Anthem Inc is a health benefits company offering a network-based managed care plans to the large and small employer, individual, Medicaid and Medicare markets. Its business segments are Commercial and ...

NYSE:ELV opened at $384.26 on Tuesday. Elevance Health has a 12 month low of $362.21 and a 12 month high of $567.26. The business’s 50-day moving average is $388.02 and its two-hundred day ...